Bitcoin $113,866.70(BTC) price of 120 thousand dollars to $ 113 thousand dollars shook the crypto currency market. However, XRP, Pi Coin and Shiba Inu (SHIB) give signals of recovery next week. Bitcoin’s market share of around 62 percent altcoinsupports a possible attack in the s. Analysts say that three Altcoin can turn negative atmosphere into an opportunity if the preservation of prominent technical levels is preserved.
Price View for XRP and Pi Coin
XRP Although the price approached the 20 -day simple moving average, the $ 3.2 threshold, but the sellers has set up the price for $ 2.8. Buyers defend the support line under the psychological threshold of $ 3. If the price remains at this level, it can collect power in the dollar band 3-3.33 per week. Otherwise, a risk of withdrawal up to $ 2.66 is on the table.

Pi Coinin the $ 0.38 in the fracture level below the price of sagging of the 20 -day average of $ 0.32 pushed. This is the first defense line of buyers. The downward breakage price can be moved to $ 0.21 and can postpone the rise scenario. Restoring the price of 0.38 dollars of the price may open the door of $ 0.45.

Critical levels for Shiba Inu
Shiba Inu The last two weeks lost 27 percent and decreased to $ 0.00001179 and deepened the downward trend. The sellers concentrated at $ 0.000014 and pushed the price below $ 0.000012. Thus, the bottom of the wide horizontal band is re -tested. The 50 -day average is $ 0,00001016 in the first reactionary support. A jump from here can bring the price of buyers on the 20 -day average.

However Shib CoinIf the price of $ 0.00001016 permanently, it will not be surprising to see $ 0.000009. While the general risk appetite in the market is weak, Bitcoin’s failure to overcome the 63 percent threshold of the market share makes Altcoin investors breathe.
Responsibility Rejection: The information contained in this article does not contain investment advice. Investors should be aware that crypto currencies carry high volatility and thus risk and carry out their operations in line with their own research.